Targeted Antibacterials
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
143
NCT02840955
The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis
Phase: N/A
Role: Collaborator
Start: Jun 30, 2016
Completion: Feb 28, 2018
NCT05827107
Skin Barrier and Microbiome of CTCL Patients
Start: Apr 3, 2023
Completion: Aug 31, 2023
Loading map...